Published in J Invest Dermatol on April 01, 1999
Systemic sclerosis: a prototypic multisystem fibrotic disorder. J Clin Invest (2007) 5.19
PAI-1 in tissue fibrosis. J Cell Physiol (2012) 2.26
Targeted disruption of TGF-beta/Smad3 signaling modulates skin fibrosis in a mouse model of scleroderma. Am J Pathol (2004) 1.77
Genetic ablation of mast cells redefines the role of mast cells in skin wound healing and bleomycin-induced fibrosis. J Invest Dermatol (2014) 1.55
Targeting IL-6 by both passive or active immunization strategies prevents bleomycin-induced skin fibrosis. Arthritis Res Ther (2014) 1.50
Transcription factor T-bet regulates skin sclerosis through its function in innate immunity and via IL-13. Proc Natl Acad Sci U S A (2007) 1.39
Essential roles for early growth response transcription factor Egr-1 in tissue fibrosis and wound healing. Am J Pathol (2009) 1.26
Advanced glycation end-products induce connective tissue growth factor-mediated renal fibrosis predominantly through transforming growth factor beta-independent pathway. Am J Pathol (2004) 1.26
CD19 regulates skin and lung fibrosis via Toll-like receptor signaling in a model of bleomycin-induced scleroderma. Am J Pathol (2008) 1.23
Amelioration of dermal fibrosis by genetic deletion or pharmacologic antagonism of lysophosphatidic acid receptor 1 in a mouse model of scleroderma. Arthritis Rheum (2011) 1.18
Cell adhesion molecules regulate fibrotic process via Th1/Th2/Th17 cell balance in a bleomycin-induced scleroderma model. J Immunol (2010) 1.07
Periostin facilitates skin sclerosis via PI3K/Akt dependent mechanism in a mouse model of scleroderma. PLoS One (2012) 1.05
Stabilization of integrin-linked kinase by the Hsp90-CHIP axis impacts cellular force generation, migration and the fibrotic response. EMBO J (2013) 1.02
Scleroderma pathogenesis: a pivotal role for fibroblasts as effector cells. Arthritis Res Ther (2013) 1.01
Clinical significance of serum HMGB-1 and sRAGE levels in systemic sclerosis: association with disease severity. J Clin Immunol (2008) 1.00
Connective tissue growth factor is induced in bleomycin-induced skin scleroderma. J Cell Commun Signal (2009) 0.97
Management of fibrosis: the mesenchymal stromal cells breakthrough. Stem Cells Int (2014) 0.96
Targeting miR-155 to Treat Experimental Scleroderma. Sci Rep (2016) 0.96
Inhibition of Notch signaling prevents experimental fibrosis and induces regression of established fibrosis. Arthritis Rheum (2011) 0.94
Measurement of matrix metalloproteinase 9-mediated collagen type III degradation fragment as a marker of skin fibrosis. BMC Dermatol (2011) 0.94
Natural IgM prevents autoimmunity by enforcing B cell central tolerance induction. J Immunol (2015) 0.93
Fibrin-induced skin fibrosis in mice deficient in tissue plasminogen activator. Am J Pathol (2005) 0.89
Simultaneous downregulation of KLF5 and Fli1 is a key feature underlying systemic sclerosis. Nat Commun (2014) 0.88
Capturing the heterogeneity in systemic sclerosis with genome-wide expression profiling. Expert Rev Clin Immunol (2011) 0.88
mPGES-1 null mice are resistant to bleomycin-induced skin fibrosis. Arthritis Res Ther (2011) 0.87
Fibrosis, vascular activation, and immune abnormalities resembling systemic sclerosis in bleomycin-treated Fli-1-haploinsufficient mice. Arthritis Rheumatol (2015) 0.85
Effect of oxidative stress on protein tyrosine phosphatase 1B in scleroderma dermal fibroblasts. Arthritis Rheum (2011) 0.85
alpha2-antiplasmin is associated with the progression of fibrosis. Am J Pathol (2009) 0.84
The role of B cells in systemic sclerosis. Biologics (2008) 0.84
Col6a1 null mice as a model to study skin phenotypes in patients with collagen VI related myopathies: expression of classical and novel collagen VI variants during wound healing. PLoS One (2014) 0.84
Proteasome inhibition prevents development of experimental dermal fibrosis. Inflammation (2012) 0.83
Identification of cadherin 11 as a mediator of dermal fibrosis and possible role in systemic sclerosis. Arthritis Rheumatol (2014) 0.83
Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis. Biomaterials (2015) 0.82
The use of streptolysin o for the treatment of scars, adhesions and fibrosis: initial investigations using murine models of scleroderma. Nonlinearity Biol Toxicol Med (2004) 0.81
Vascular changes in bleomycin-induced scleroderma. Int J Rheumatol (2011) 0.81
Knockout of endothelial cell-derived endothelin-1 attenuates skin fibrosis but accelerates cutaneous wound healing. PLoS One (2014) 0.80
Plasminogen activator inhibitor-1 is elevated, but not essential, in the development of bleomycin-induced murine scleroderma. Clin Exp Immunol (2005) 0.80
A modified murine model of systemic sclerosis: bleomycin given by pump infusion induced skin and pulmonary inflammation and fibrosis. Lab Invest (2014) 0.79
The Tsk2/+ mouse fibrotic phenotype is due to a gain-of-function mutation in the PIIINP segment of the Col3a1 gene. J Invest Dermatol (2014) 0.79
Combined effect of genetic background and gender in a mouse model of bleomycin-induced skin fibrosis. Arthritis Res Ther (2015) 0.79
Thyroid hormones inhibit TGF-β signaling and attenuate fibrotic responses. Proc Natl Acad Sci U S A (2016) 0.78
Abnormal B lymphocyte activation and function in systemic sclerosis. Ann Dermatol (2015) 0.78
Interstitial lung disease in systemic sclerosis: current and future treatment. Rheumatol Int (2017) 0.78
Effectiveness of palosuran in bleomycin-induced experimental scleroderma. Inflammation (2013) 0.77
Thalidomide has a therapeutic effect on interstitial lung fibrosis: evidence from in vitro and in vivo studies. Clin Exp Immunol (2009) 0.76
UVA1 irradiation inhibits fibroblast proliferation and alleviates pathological changes of scleroderma in a mouse model. J Biomed Res (2012) 0.76
Geniposide inhibited endothelial-mesenchymal transition via the mTOR signaling pathway in a bleomycin-induced scleroderma mouse model. Am J Transl Res (2017) 0.75
Keloids: Animal models and pathologic equivalents to study tissue fibrosis. Matrix Biol (2016) 0.75
Role of Transforming Growth Factor-β1 and Smads Signaling Pathway in Intrauterine Adhesion. Mediators Inflamm (2016) 0.75
Protective role for miR-9-5p in the fibrogenic transformation of human dermal fibroblasts. Fibrogenesis Tissue Repair (2016) 0.75
Animal models of systemic sclerosis: their utility and limitations. Open Access Rheumatol (2014) 0.75
The protective effect of hydrogen sulfide on systemic sclerosis associated skin and lung fibrosis in mice model. Springerplus (2016) 0.75
Knockout of endothelin type B receptor signaling attenuates bleomycin-induced skin sclerosis in mice. Arthritis Res Ther (2016) 0.75
PDGF-BB Promotes Type I IFN-Dependent Vascular Alterations and Monocyte Recruitment in a Model of Dermal Fibrosis. PLoS One (2016) 0.75
Fibroblast-Derived MMP-14 Regulates Collagen Homeostasis in Adult Skin. J Invest Dermatol (2016) 0.75
Characterization of a Novel Dermal Fibrosis Model Induced by Areca Nut Extract that Mimics Oral Submucous Fibrosis. PLoS One (2016) 0.75
Mutations in the catalytic domain of human matrix metalloproteinase-1 (MMP-1) that allow for regulated activity through the use of Ca2+. J Biol Chem (2013) 0.75
New fat-derived products for treating skin-induced lesions of scleroderma in nude mice. Stem Cell Res Ther (2014) 0.75
Origin of fibrosing cells in systemic sclerosis. Curr Opin Rheumatol (2015) 0.75
Decreased interleukin-20 expression in scleroderma skin contributes to cutaneous fibrosis. Arthritis Rheumatol (2014) 0.75
Gene expression profiling of human dermal fibroblasts exposed to bleomycin sulphate does not differentiate between radiation sensitive and control patients. Radiat Oncol (2011) 0.75
A convenient method for producing the bleomycin-induced mouse model of scleroderma by weekly injections using a methylcellulose gel. Rheumatol Int (2011) 0.75
Control of mating preferences in mice by genes in the major histocompatibility complex. J Exp Med (1976) 5.52
The complete nucleotide sequences of the cloned hepatitis B virus DNA; subtype adr and adw. Nucleic Acids Res (1983) 5.41
A phase II trial of gefitinib as first-line therapy for advanced non-small cell lung cancer with epidermal growth factor receptor mutations. Br J Cancer (2006) 4.46
Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology (1990) 4.43
Hepatitis C in hospital employees with needlestick injuries. Ann Intern Med (1991) 4.24
Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: proposals for standardization. International Committee on Virus Taxonomy. Arch Virol (1998) 3.77
Recognition among mice. Evidence from the use of a Y-maze differentially scented by congenic mice of different major histocompatibility types. J Exp Med (1979) 3.23
Detection of Australia antigen by means of immune adherence haemagglutination test. Vox Sang (1971) 2.88
Distinctive urinary odors governed by the major histocompatibility locus of the mouse. Proc Natl Acad Sci U S A (1981) 2.68
Selective reduction of T cells bearing invariant V alpha 24J alpha Q antigen receptor in patients with systemic sclerosis. J Exp Med (1995) 2.63
Relationship between periodontal infections and systemic disease. Clin Microbiol Infect (2007) 2.56
Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci U S A (1998) 2.37
Chronic inflammatory arthropathy associated with HTLV-I. Lancet (1989) 2.28
Induction of inflammatory arthropathy resembling rheumatoid arthritis in mice transgenic for HTLV-I. Science (1991) 2.18
Increased interleukin-17 production in patients with systemic sclerosis. Arthritis Rheum (2000) 2.13
Spleen-preserving distal pancreatectomy with conservation of the splenic artery and vein. Surgery (1996) 2.12
Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans cell histiocytosis. Cancer (1993) 2.03
Identification of human MutY homolog (hMYH) as a repair enzyme for 2-hydroxyadenine in DNA and detection of multiple forms of hMYH located in nuclei and mitochondria. Nucleic Acids Res (2000) 2.00
A cholesteryl ester transfer protein inhibitor attenuates atherosclerosis in rabbits. Nature (2000) 1.99
Embryotoxic effects of ethylene glycol monomethyl ether in mice. Toxicology (1981) 1.95
FGF-2 stimulates periodontal regeneration: results of a multi-center randomized clinical trial. J Dent Res (2010) 1.92
Inhibition of spontaneous metastasis in a rat prostate cancer model by oral administration of modified citrus pectin. J Natl Cancer Inst (1995) 1.92
Volatile signals of the major histocompatibility complex in male mouse urine. Proc Natl Acad Sci U S A (1997) 1.91
"Tuftsin": a natural phagocytosis stimulating peptide. Nature (1970) 1.88
Endophytic colonization and in planta nitrogen fixation by a Herbaspirillum sp. isolated from wild rice species. Appl Environ Microbiol (2001) 1.86
Apoptosis and functional Fas antigen in rheumatoid arthritis synoviocytes. Arthritis Rheum (1995) 1.85
Recognition of H-2 types in relation to the blocking of pregnancy in mice. Science (1983) 1.83
Sensory distinction between H-2b and H-2bm1 mutant mice. Proc Natl Acad Sci U S A (1983) 1.79
Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers. Int J Clin Pharmacol Ther Toxicol (1993) 1.79
Sialolipoma: a report of seven cases of a new variant of salivary gland lipoma. Histopathology (2001) 1.77
Primary hepatic lymphoma associated with primary biliary cirrhosis. Am J Gastroenterol (1999) 1.77
Pseudoeosinophilia, eosinophilic endocarditis and eosinophilic leukemia. Am J Med (1972) 1.72
"Transmural air leak": a computed tomographic finding following endoscopic submucosal dissection of gastric tumors. Endoscopy (2010) 1.69
Expression of E-cadherin and beta-catenin in human non-small cell lung cancer and the clinical significance. Clin Cancer Res (2000) 1.69
Clinical manifestations in anticardiolipin antibody-positive patients with progressive systemic sclerosis. J Am Acad Dermatol (1990) 1.67
Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects. J Clin Pharmacol (1993) 1.66
Beneficial effect of prodromal angina pectoris is lost in elderly patients with acute myocardial infarction. Am Heart J (2000) 1.66
alpha-synuclein accumulation in skin nerve fibers revealed by skin biopsy in pure autonomic failure. Neurology (2010) 1.65
Untreated ocular hypertension. A long-term prospective study. Arch Ophthalmol (1977) 1.62
Chemosensory recognition of phenotypes determined by the Tla and H-2K regions of chromosome 17 of the mouse. Proc Natl Acad Sci U S A (1982) 1.59
Delayed onset and reduced severity of collagen-induced arthritis in interleukin-6-deficient mice. Arthritis Rheum (1999) 1.57
Complement and tumor immunology. Adv Cancer Res (1971) 1.57
Antitumor cytotoxicity mediated by ligand-activated human V alpha24 NKT cells. Cancer Res (1999) 1.55
Augmented interleukin-1 production and HLA-DR expression in the synovium of rheumatoid arthritis patients. Possible involvement in joint destruction. Arthritis Rheum (1988) 1.54
Distribution of patients with 2,8-dihydroxyadenine urolithiasis and adenine phosphoribosyltransferase deficiency in Japan. J Urol (1988) 1.53
Lysosomal and ultrastructural changes in human "toxic" neutrophils during bacterial infection. J Exp Med (1969) 1.53
Comparative sequence analyses of the genes coding for 16S rRNA of Lactobacillus casei-related taxa. Int J Syst Bacteriol (1997) 1.53
Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference. Pigment Cell Melanoma Res (2012) 1.48
Significance of elevated serum LDH (lactate dehydrogenase) activity in atopic dermatitis. J Dermatol (1990) 1.48
Mucous gland adenoma of the trachea resected with an endoscopic neodymium: yttrium aluminum garnet laser. Intern Med (1996) 1.48
Eighteen cases exposed to sarin in Matsumoto, Japan. Intern Med (1997) 1.47
Central role of mitochondria and p53 in Fas-mediated apoptosis of rheumatoid synovial fibroblasts. Rheumatology (Oxford) (2003) 1.47
Distinct C-terminus of the B subunit of factor XIII in a population-associated major phenotype: the first case of complete allele-specific alternative splicing products in the coagulation and fibrinolytic systems. J Thromb Haemost (2009) 1.45
Chemosensory recognition of mouse major histocompatibility types by another species. Proc Natl Acad Sci U S A (1985) 1.45
Functional CD86 (B7-2/B70) is predominantly expressed on Langerhans cells in atopic dermatitis. Br J Dermatol (1997) 1.44
Genetic and clinical studies on 19 families with adenine phosphoribosyltransferase deficiencies. Hum Genet (1987) 1.43
Spontaneous production of an interleukin 1-like factor by cloned rheumatoid synovial cells in long-term culture. J Clin Invest (1987) 1.42
A large outbreak of acute gastroenteritis associated with astrovirus among students and teachers in Osaka, Japan. J Infect Dis (1994) 1.42
Annular erythema associated with primary Sjögren syndrome: analysis of T cell subsets in cutaneous infiltrates. J Am Acad Dermatol (1989) 1.42
HbA(1c) variability and the development of microalbuminuria in type 2 diabetes: Tsukuba Kawai Diabetes Registry 2. Diabetologia (2012) 1.41
Pharyngeal perforation following endotracheal intubation in a patient with rheumatoid arthritis. J Anesth (1993) 1.39
Prospective study of the clinical value of determining circulating IgA-alpha 1-antitrypsin complex using a prototype ELISA kit in patients with rheumatoid arthritis. Ann Rheum Dis (1996) 1.39
[The significance of heparin concentration measurement during cardiopulmonary bypass--effect of heparin-coated circuit during normothermic bypass]. Nihon Kyobu Geka Gakkai Zasshi (1997) 1.39
A plant DNA-binding protein increases the number of active preinitiation complexes in a human in vitro transcription system. Genes Dev (1990) 1.39
Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis (1999) 1.38
Radiation-induced erythema nodosum. Br J Dermatol (1999) 1.38
Impaired sweating as an exocrine manifestation in Sjögren's syndrome. Br J Dermatol (1995) 1.38
Cutaneous metastases from carcinoma of the cervix resemble acquired lymphangioma. J Am Acad Dermatol (1994) 1.38
Potent antitumor activity of MS-247, a novel DNA minor groove binder, evaluated by an in vitro and in vivo human cancer cell line panel. Cancer Res (1999) 1.37
Isolation and characterization of a complementary DNA expressing human U1 small nuclear ribonucleoprotein C polypeptide. J Immunol (1988) 1.37
Reduction of complement in Behçet's disease and drug allergy. Med Biol (1974) 1.36
Human APE2 protein is mostly localized in the nuclei and to some extent in the mitochondria, while nuclear APE2 is partly associated with proliferating cell nuclear antigen. Nucleic Acids Res (2001) 1.35
Single tottering mutations responsible for the neuropathic phenotype of the P-type calcium channel. J Biol Chem (1998) 1.35
Endobronchial ultrasonography with guide-sheath for peripheral pulmonary lesions. Eur Respir J (2004) 1.35
Toll-like receptors confer responsiveness to lipopolysaccharide from Porphyromonas gingivalis in human gingival fibroblasts. Infect Immun (2000) 1.33
Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type-1 (HIV-1) infection. Microbiol Immunol (1996) 1.33
Particulate tyrosinase of human malignant melanoma. Solubilization, purification following trypsin treatment, and characterization. Eur J Biochem (1978) 1.32
Plasma endothelin concentrations in patients with pulmonary hypertension associated with congenital heart defects. Evidence for increased production of endothelin in pulmonary circulation. Circulation (1991) 1.32
Hepatitis B antigen, antigen subtypes, and hepatitis B antibody in normal subjects and patients with liver disease. Bull World Health Organ (1975) 1.29
Endothelial apoptosis induced by oxidative stress through activation of NF-kappaB: antiapoptotic effect of antioxidant agents on endothelial cells. Hypertension (2001) 1.28
Intralesional steroid-therapy-induced reduction of plasma interleukin-6 and improvement of cutaneous plasmacytosis. Dermatology (1995) 1.28
Long-term follow-up of the changes in circulating cytokines, soluble cytokine receptors, and white blood cell subset counts in patients with rheumatoid arthritis (RA) after monoclonal anti-TNF alpha antibody therapy. J Clin Immunol (1999) 1.28
Antiproliferative activity of REIC/Dkk-3 and its significant down-regulation in non-small-cell lung carcinomas. Biochem Biophys Res Commun (2001) 1.27
Autoantibodies to T cell costimulatory molecules in systemic autoimmune diseases. J Immunol (1999) 1.26
Destructive periodontitis lesions are determined by the nature of the lymphocytic response. Crit Rev Oral Biol Med (2002) 1.26
Pseudolymphomatous folliculitis: a clinicopathologic study of 15 cases of cutaneous pseudolymphoma with follicular invasion. Am J Surg Pathol (1999) 1.26
Diabetes mellitus prevents ischemic preconditioning in patients with a first acute anterior wall myocardial infarction. J Am Coll Cardiol (2001) 1.26
A significant role of stromal fibroblasts in rapidly progressive dry eye in patients with chronic GVHD. Invest Ophthalmol Vis Sci (2001) 1.25
Accumulation of multiple T cell clonotypes in the synovial lesions of patients with rheumatoid arthritis revealed by a novel clonality analysis. Int Immunol (1992) 1.24
Ultrastructural demonstration of apoptosis, Fas and Bcl-2 expression of rheumatoid synovial fibroblasts. J Rheumatol (1996) 1.22
Immunological and immunohistochemical analysis of rheumatoid nodules. Ann Rheum Dis (1989) 1.22
The role of C-C chemokines and their receptors in osteoarthritis. Arthritis Rheum (2001) 1.20
Visceral antinociceptive effects of spinal clonidine combined with morphine, [D-Pen2, D-Pen5] enkephalin, or U50,488H. Anesthesiology (1995) 1.20